Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Obeso

Showing results (291-300 of 539) with videos related to

Pageof 54
Sort By:
Advances in Experimental Medicine and Biology|May 11, 2006
An overview on the homeostasis of Ca2+ in chemoreceptor cells of the rabbit and rat carotid bodiesS V Conde, A I Caceres, I Vicario, et al.
Psychopharmacology|January 23, 2009
Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned ratsC Marin, E Aguilar, M C Rodríguez-Oroz, et al.
Brain Research|October 8, 1993
Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentumM T Herrero, E C Hirsch, F Javoy-Agid, et al.
Annals of Neurology|April 13, 2000
Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current modelJ A Obeso, M C Rodriguez-Oroz, M Rodriguez, et al.
News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society|March 23, 2002
The basal ganglia and disorders of movement: pathophysiological mechanismsJosé A Obeso, María C Rodríguez-Oroz, Manuel Rodríguez, et al.
Neurobiology of Disease|August 30, 2008
Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changesC Marin, E Aguilar, G Mengod, et al.
Experimental Neurology|October 22, 2013
Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's diseaseC Marin, M Bonastre, G Mengod, et al.
Brain : a Journal of Neurology|June 1, 1989
The treatment of severe action myoclonusJ A Obeso, J Artieda, J C Rothwell, et al.
Annals of Neurology|January 1, 1982
Lithium therapy in torsion dystoniaJ F Marti-Masso, J A Obeso, N Carrera, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1992
Abnormal muscle and skin mitochondria in family with myoclonus, ataxia, and deafness (May and White syndrome)J Vaamonde, J Muruzabal, T Tuñón, et al.
Pageof 54

Showing results (291-300 of 539) with videos related to

Sort By:
Pageof 54
Advances in Experimental Medicine and Biology|May 11, 2006
An overview on the homeostasis of Ca2+ in chemoreceptor cells of the rabbit and rat carotid bodiesS V Conde, A I Caceres, I Vicario, et al.
Psychopharmacology|January 23, 2009
Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned ratsC Marin, E Aguilar, M C Rodríguez-Oroz, et al.
Brain Research|October 8, 1993
Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentumM T Herrero, E C Hirsch, F Javoy-Agid, et al.
Annals of Neurology|April 13, 2000
Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current modelJ A Obeso, M C Rodriguez-Oroz, M Rodriguez, et al.
News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society|March 23, 2002
The basal ganglia and disorders of movement: pathophysiological mechanismsJosé A Obeso, María C Rodríguez-Oroz, Manuel Rodríguez, et al.
Neurobiology of Disease|August 30, 2008
Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changesC Marin, E Aguilar, G Mengod, et al.
Experimental Neurology|October 22, 2013
Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's diseaseC Marin, M Bonastre, G Mengod, et al.
Brain : a Journal of Neurology|June 1, 1989
The treatment of severe action myoclonusJ A Obeso, J Artieda, J C Rothwell, et al.
Annals of Neurology|January 1, 1982
Lithium therapy in torsion dystoniaJ F Marti-Masso, J A Obeso, N Carrera, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1992
Abnormal muscle and skin mitochondria in family with myoclonus, ataxia, and deafness (May and White syndrome)J Vaamonde, J Muruzabal, T Tuñón, et al.
Pageof 54